Skip to content

Expression of Target in Endometriotic Lesions

To Investigate the Expression of Target in Endometriotic Lesions

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07693283
Enrollment
40
Registered
2026-07-09
Start date
2026-04-13
Completion date
2027-02-12
Last updated
2026-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Brief summary

Endometriosis is a common gynecological disorder associated with chronic pelvic pain and infertility, which affects women of reproductive age worldwide. This study aims to investigate the expression patterns of specific molecules in tissue specimens obtained from patients with endometriosis. The investigators will compare the expression levels of these molecules between endometriotic lesions and normal tissue. The primary objective of this study is to elucidate the potential roles of these molecules in the pathogenesis of endometriosis.

Interventions

OTHERRetrospective molecular expression analysis in endometriosis tissue specimens

This study involves no prospective interventional measures for participants.

Sponsors

Beijing Tsinghua Chang Gung Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Pathologically confirmed endometriosis via laparoscopy and histopathological examination * Complete clinical and pathological data available

Exclusion criteria

• History of any malignant tumor

Design outcomes

Primary

MeasureTime frameDescription
Expression levels of molecular in endometriotic lesions and adjacent normal tissue6 monthsStandardized pathological histology assessment method

Countries

China

Contacts

CONTACTLei Zhang
461458953@qq.com+86 186 0113 0459
PRINCIPAL_INVESTIGATORLei Zhang

Beijing Tsinghua Changgeng Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 10, 2026